Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Friday
Nov 21st
Amoxycilin + Clavulanate, susp. Print E-mail
Member of Farmavita.net is offering dossier in European CTD format for Amoxycilin + Clavulanate, 125+31 mg; 250+63 mg, suspension.

Dossier is submitted in reference member state.

License for use of Dossier is related to initial downpayment and commitment to bulk purchase.  

Amoxycilin + Clavulanate is classified as an anti-infective, according ATC index.

Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. 

Comments
Search RSS
meetvishal   |Author |2007-08-14 07:54:43
Hi,

How many company has Marketing Authorization for the
Product?

Regards,

Vishal
Only registered users can write comments!

3.20 Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network
 
< Prev   Next >
Advertisement
 

Featured Video

Free Hugs Campaign

Free hugs for everyone! Read more ...

Login to Farmavita.Net

membership is FREE

BabelFish Translator




Click Flag for Translation

Who's Online

We have 1 guest online

Tag Clouds

country

Joomla Modul

Farmavita.Net RSS News


Products

Click to Products

News

Click to News

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS